To investigate it, we calculated immune signatures with Gene Set Variation Analysis (GSVA) and applied them to the lung transcriptome followed by unbiased cluster analysis of GSVA immune-enrichment scores, in 109 IPF patients from the Lung Tissue Research Consortium (LTRC)
Since 2001 the GOLD publishes and updates every year a document that recommends how to best diagnose and manage COPD. The GOLD 2024 document has just been released and is available for free download in the GOLD website.
Fibrogenesis is part of a normal protective response to tissue injury that can become irreversible and progressive, leading to fatal diseases.
The GOLD 2023 report identifies different causes (etiotypes) of COPD. Their prevalence in individuals in the general population with persistent airflow obstruction (PAO) is unknown.
TT guided asthma management for 10 weeks reduced T2 inflammation.
«Biologics for COPD — Finally Here» highlighted as one of the notable articles among the featured selections on NEJM Notable Articles of 2023
Chronic obstructive pulmonary disease (COPD) is a major public health problem that remains largely neglected.
Reunión del programa ANTES Noviembre 2023: Los expertos expresan que el objetivo de “evitar futuras exacerbaciones y complicaciones asociadas, así como frenar la progresión de la EPOC».
Primer Encuentro Anual de Pacientes de Chiesi: punto de encuentro de referencia y foro de debate y discusión para pacientes, profesionales sanitarios, así como otros agentes del sector salud, con el fin de ayudar a visibilizar sus necesidades.
El 22/02/2024 se celebrará el V Congreso del Instituto de Experiencia del Paciente (IEXP). El Dr. Alvar Agustí participará en la Mesa: Innovación en procesos y tecnología desde la experiencia de paciente.
